ClinicalTrials.gg
RecruitingNCT04788524Updated May 19, 2026

Neural Correlates of Stress and Perceived Control in Adolescent Depression

An interventional study of Computer Task Manipulation in Major Depressive Disorder, sponsored by Mclean Hospital. Recruiting at 1 site in United States. Open to female participants aged 14 Years to 18 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-05-19.

Sponsored by Mclean Hospital · Not applicable, Interventional, and Basic science

How we know

From the registry’s dates

  • Started Apr 2021; still recruiting 5 years 6 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Not applicable
Ages
14 Years to 18 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 32 studies in Depressive Disorder, Major by Mclean Hospital — 7 open to participants now, 7 under way, none of them phase 3. Depressive Disorder, Major · Mclean Hospital.

Planned enrollment
10th of 22
80 · median 80
Started
2021
with 1 other
No phase
8 of 32
2 open now
Registered
25th of 32
by date

Among the 32 studies in Depressive Disorder, Major by Mclean Hospital, this one is the 10th largest by planned enrollment of the 22 interventional ones that give a count, is one of 2 that started in 2021, is one of 8 with no phase, and was the 25th registered.

Depressive Disorder, Major

3,051 studies on the registry are indexed under Depressive Disorder, Major; 596 are open to participants now.

Browse Depressive Disorder, Major studies →

Open to participants now

7 of the 32 studies in Depressive Disorder, Major by Mclean Hospital are open now, in 1 country. Recruiting first, the newest first:

1 more — sign in →

By country, each count listing its studies:

All 7 open studies →

Where they have run

Who these studies take

Of the 419 Depressive Disorder, Major studies recruiting now, 93 (22%) set no upper age limit and 299 (71%) stop at 75 or younger; 55 take children under 18; 100 take healthy volunteers.

This study: 14 Years to 18 Years · female · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 32 studies in Depressive Disorder, Major by Mclean Hospital, or all of them as a file.
02

Study summary

Lack of perceived control, particularly during stress, has been critically implicated in major depressive disorder (MDD) and anhedonic symptoms, especially among female adolescents; yet the neural underpinnings of perceived control disruptions in MDD remain poorly understood. Using functional magnetic resonance imaging with a novel "value of control task" in conjunction with a prospective design, this study will provide a comprehensive understanding of stress and perceived control related mechanisms in female adolescents with MDD and will examine stress-induced disruptions in perceived control as a predictor of "real world" expressions of maladaptive coping and anhedonia.

Read the detailed description

Participants in this research will include 40 female adolescents, aged 14-18, with Major Depressive Disorder (MDD) and 40 healthy adolescents from the greater Boston area by Dr. Emily Belleau, at McLean Hospital's Center for Depression, Anxiety and Stress Research.

The study will include four sessions:

  • A clinical diagnostic interview as well as filling out a series of questionnaires and assessments.
  • The second session will include a functional magnetic resonance imaging (fMRI) brain scan to be conducted at the McLean Hospital Imaging Center. Participants will be asked to respond to surveys on their cell phone in the week following the fMRI brain scan.
  • The third session will include a diagnostic interview, assessments, and questionnaires to be completed three-months after the fMRI brain scan. Participants will be asked to complete surveys on their cell phone during the week following this three month follow-up session.
  • The fourth session will include a diagnostic interview, assessments, and questionnaires to be completed six-months after the fMRI brain scan. Participants will be asked to complete surveys on their cell phone during the week following this six month follow-up session.
03

Conditions studied

  • Major Depressive Disorder

Keywords

  • stress
  • perceived control
  • neuroimaging
  • depression
04

Who can participate

Ages eligible
14 Years to 18 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Inclusion Criteria: All Participants

    1. Females of all ethnic origins See Section: Inclusion of Women and Minorities);
    2. Ages 14-18 (See Section: Inclusion of Children);
    3. Written informed assent/consent from adolescent and parent/guardian (if under age 18);
    4. English as a first language or English fluency;
    5. Right handed111;
    6. Personal cell-phone (for Ecological Momentary Assessment [EMA]) 7 All participants will be in the follicular phase of their menstrual cycle when completing the functional magnetic resonance imaging (fMRI) study session

Inclusion Criteria: MDD Sample

  1. Meet Diagnostic Statistical Manual-5th edition () diagnostic criteria for major depressive disorder (as diagnosed with the KSADS)
  2. Absence of any psychotropic medications for at least 2 weeks (6 weeks for fluoxetine; 6 months for neuroleptics; 2 weeks for benzodiazepines; 2 weeks for any other antidepressants);

Inclusion Criteria: Healthy Control (HC) Sample

  1. No history or current diagnosis of any DSM-5 psychiatric or substance/alcohol-related disorder (as diagnosed with the KSADS)
  2. No first-degree relatives with a history of depression, bipolar disorder, or psychosis

Exclusion criteria

Exclusion Criteria:

  • Exclusion Criteria: All Participants

    1. History of head trauma with loss of consciousness;
    2. History of seizure disorder;
    3. Serious or unstable medical illness including cardiovascular, hepatic, renal, respiratory, endocrine, neurologic or hematologic disease;
    4. History of cocaine or stimulant use (e.g., amphetamine, cocaine, methamphetamine);
    5. History of use of dopaminergic drugs (including methylphenidate);
    6. Use of hormonal replacement therapy, anabolic steroids, or hormonal ;
    7. Clinical or laboratory evidence of hypothyroidism;
    8. Systemic medical or neurological illness that could impact fMRI measures of cerebral blood flow;
    9. Failure to meet standard exclusion criteria for fMRI scanning (e.g., claustrophobia, cardiac pacemakers, neural pacemakers, surgically implanted metal devices, cochlear implants, metal braces, or other metal objects in the body);
    10. Pregnancy
    11. Testing positive on a drug test on the day of the scan which testis for stimulants, marijuana, barbiturates, benzodiazepine, buprenorphine, 3,4-Methyl enedioxy methamphetamine (MDMA), methadone, opiates, oxycodone, phencyclidine;
    12. History of electroconvulsive therapy
    13. Participants with suicidal ideation where study participation is deemed unsafe by the study clinician;

Additional Exclusion Criteria: Major Depressive Disorder (MDD) Sample

1. Major depressive disorder diagnosis secondary to another disorder (selected comorbid anxiety disorders such as generalized anxiety disorder, specific phobia, and social anxiety disorders are allowed if they are secondary to MDD)

Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

DSM diagnostic criteria

The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.

Contraception

Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.

Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
80 participants (estimated)

Study arms

  • Experimental
    Computer Task Manipulation

    Participants will complete computer tasks while undergoing an fMRI brain scan

    Behavioral: Computer Task Manipulation

Interventions

  • BehavioralComputer Task Manipulation

    Participants will complete computer tasks.

06

What researchers measure

Primary outcomes

  1. Blood-Oxygen-Level-Dependent Imaging (BOLD) activation of the ventral striatum and ventral medial prefrontal cortex

    BOLD activation of frontostriatal regions in response to computer tasks performed during the fMRI Brian scan

    Time frame: 1.5 hour long scan during session 2

Secondary outcomes

  1. Cortisol Rating

    Saliva rating to be collected throughout the fMRI brain scan

    Time frame: collected as part of 1.5 hour long scan during session 2

  2. Mood Rating

    Self-reported mood rating to be collected throughout the fMRI brain scan

    Time frame: collected as part of 1.5 hour long scan during session 2

  3. Stress Reactivity Score

    Stress Reactivity Survey Item collected via smart-phone delivered ecological momentary assessment

    Time frame: Longitudinal, three time points (baseline, 3-month follow-up, 6-month follow-up)

  4. Stress Reactive Rumination Score

    Stress Reactive Rumination Scale collected via smart-phone delivered ecological momentary assessment

    Time frame: Longitudinal, three time points (baseline, 3-month follow-up, 6-month follow-up)

  5. Positive Affect Score

    Positive Affect Survey Items collected via smart-phone delivered ecological momentary assessment

    Time frame: Longitudinal, three time points (baseline, 3-month follow-up, 6-month follow-up)

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2021 (actual). Primary completion is estimated for Oct 2026, 66 months after the start.

Of 654 non-industry interventional studies with no phase under Depressive Disorder, Major, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 55. This study's planned 66 months is above that.

Counting every sponsor, half of 694 studies reached it within 33 months; a quarter within 17 and three quarters within 55.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 3, 2021
First posted
Mar 9, 2021
StartActual
Apr 23, 2021
Primary completionEst.
Oct 31, 2026
CompletionEst.
Oct 31, 2026
Last update
May 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 19, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04788524
Lead sponsor
Mclean Hospital
Responsible party
Emily L. Belleau (Principal Investigator, Mclean Hospital) — Principal investigator
First posted
Mar 9, 2021
Start date
Apr 23, 2021
Primary completion
Oct 31, 2026 (estimated)
Completion
Oct 31, 2026 (estimated)
Last update
May 19, 2026

Study contacts

Emily L Belleau, PhD
Contact
ebelleau@mclean.harvard.edu
6178554245
Emily L Belleau, PhD
principal investigator · Mclean Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion